Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias-Reference-Cited by-同舟云学术

Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias

Published:2024-06-14 Issue:12 Volume:25 Page:6570
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Gonçalves Ana Cristina¹²³^ORCID,Alves Raquel¹²³^ORCID,Sarmento-Ribeiro Ana Bela¹²³⁴^ORCID

Affiliation:

1. Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal

2. Coimbra Institute for Clinical and Biomedical Research (iCBR)—Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal

3. Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal

4. Hematology Service, Centro Hospitalar Universitário de Coimbra, Unidade Local de Saúde de Coimbra, 3000-061 Coimbra, Portugal

Abstract

Hematological neoplasias are among the most common cancers worldwide, and the number of new cases has been on the rise since 1990, reaching 1 [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/12/6570/pdf

Reference24 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Global Burden of Hematologic Malignancies and Evolution Patterns over the Past 30 Years;Zhang;Blood Cancer J.,2023

3. Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.Cell.2018.02.060));Bailey;Cell,2018

4. Tumor Biomarkers for Diagnosis, Prognosis and Targeted Therapy. Signal Transduct;Zhou;Target. Ther.,2024

5. Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care;Tsimberidou;JCO Oncol. Pract.,2024